(Q45252599)

11 December 2017

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study (English)

1 reference

11 December 2017

1 reference

3

1 reference

11 December 2017

A J Risselada

1

1 reference

11 December 2017

J Vehof

2

1 reference

11 December 2017

B Wilffert

4

1 reference

11 December 2017

D Cohen

5

1 reference

11 December 2017

A F Al Hadithy

6

1 reference

11 December 2017

J Arends

7

1 reference

11 December 2017

H Mulder

8

1 reference

11 December 2017

3 August 2010

1 reference

The Pharmacogenomics Journal

11 December 2017

1 reference

11 December 2017

12

1 reference

11 December 2017

1

1 reference

11 December 2017

62-67

1 reference

https://scigraph.springernature.com/pub.10.1038/tpj.2010.66

11 December 2017

0 references

cites work

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Prevalence of metabolic syndrome in patients with psychotic disorders in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Identifying people with metabolic syndrome in primary care by screening with a mailed tape measure: a survey of 14,000 people in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Beyond the "hype" on the association between metabolic syndrome and atypical antipsychotics: the confounding effects of cohort, typical antipsychotics, severe mental illness, comedications, and comorbid substance use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

ARC-1, a sequence element complementary to an internal 18S rRNA segment, enhances translation efficiency in plants when present in the leader or intercistronic region of mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Simulation study of confounder-selection strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

What's wrong with Bonferroni adjustments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

-759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.66

21 January 2018

Identifiers

DOI

10.1038/TPJ.2010.66

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference